|
Cost-effectiveness of extended buprenorphine naloxone treatment for opioid-dependent youth: data from a randomized trial |
Polsky D, Glick HA, Yang J, Subramaniam GA, Poole SA, Woody GE |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Polsky D, Glick HA, Yang J, Subramaniam GA, Poole SA, Woody GE. Cost-effectiveness of extended buprenorphine naloxone treatment for opioid-dependent youth: data from a randomized trial. Addiction 2010; 105(9): 1616-1624 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Ambulatory Care /economics; Buprenorphine /economics /therapeutic use; Buprenorphine, Naloxone Drug Combination; Child; Cost of Illness; Cost-Benefit Analysis; Counseling; Drug Combinations; Humans; Naloxone /economics /therapeutic use; Narcotic Antagonists /economics /therapeutic use; Opioid-Related Disorders /economics /rehabilitation /urine; Outcome Assessment (Health Care); Quality-Adjusted Life Years; Substance Abuse Detection; Substance Abuse Treatment Centers; United States; Young Adult AccessionNumber 22011000179 Date bibliographic record published 06/04/2011 |
|
|
|